Prelude Therapeutics Incorporated
BCL-2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS
Last updated:
Abstract:
The disclosure is directed to, in part, to BCL-2 inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.
Status:
Application
Type:
Utility
Filling date:
27 Apr 2021
Issue date:
11 Nov 2021